Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Alaska for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Alaska only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Alaska (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Lawrence Lawson (NPI 1740243914)

Field	Value
Entity Type	Individual
Organization	Lawrence Lawson
Address	2490 S Woodworth Loop Ste 499
City	Palmer
State	AK
ZIP	99645
Taxonomy	Medical Oncology Physician
NPI Enumerated	April 10, 2006

Payer Source	Total Paid
Medicare	$779K
Medicaid	$0

Key Findings

Practice is functionally an oncology infusion service centered on high-cost biologic/immune therapies: the single largest code is J9271 with $421.4K revenue (54.6% of Medicare revenue) and 9.8K claims, followed by J0897 with $159.8K revenue (20.7%) and 8.9K claims. The prominence of infusion/biologic J-codes alongside chemotherapy administration codes such as 96413 (214 claims, $24.6K) and add-on infusion codes (96417, 96415) indicates a clinical model built around in‑office drug delivery and on-site infusion services rather than solely office visits. This aligns with the provider taxonomy (Medical Oncology Physician) and the presence of supportive care codes like 96365 and 96367.

Revenue is highly concentrated in a small set of drug and evaluation codes: the precomputed top-three codes account for 85.9% of this provider's total Medicare revenue, with J9271 alone representing $421.4K (54.6%). That concentration implies that changes in utilization or reimbursement for those specific drugs would materially affect the provider's Medicare revenue stream.

This provider is effectively single-payer Medicare in scope: lifetime Medicare revenue is $779K while there is no Medicaid billing on file. With Medicaid activity absent, payer mix analysis should treat the practice as relying almost entirely on Medicare beneficiaries and associated Medicare Part B drug reimbursement.

Competitive standing on key oncology drug codes is modest to typical rather than dominant: J9271 ranks #1206 of 1841 (34th percentile; typical, unremarkable volume) and J0897 ranks #1366 of 10057 (86th percentile; typical, unremarkable volume). These rankings suggest the practice is not a national outlier or regional leader for pembrolizumab or denosumab administration despite large absolute dollars, while office evaluation volume differs (see next point).

Office visit volume is a relative strength: 99214 generated $82K (10.6% of Medicare revenue) across 672 claims and ranks #28449 of 479517 (94th percentile; notably above typical national volume). This indicates above-typical ambulatory evaluation and management activity for an oncology provider, suggesting the practice combines high-intensity drug delivery with frequent moderate-complexity follow-up visits.

Clinical support services and monitoring appear embedded in the workflow: lab codes 80053 (626 claims, $6.3K) and 85025 (770 claims, $6.2K) along with frequent venipuncture (36415, 417 claims) indicate routine on-site laboratory monitoring and specimen collection to support infusion and chemotherapy services. These ancillary services are small revenue contributors individually but demonstrate integrated clinical care rather than referral-only drug administration.

Tenure and enrollment history show a long-established Medicare presence: NPI enumerated 2006-04-10 (~20 years ago), implying continuity of billing patterns and potential stability in local market presence. Analysts should treat trends as coming from an established practice rather than a recent entrant.

Across the broader CPT/HCPCS mix, administration and supportive infusion codes generally fall into the “typical, unremarkable volume” category (examples include 96413 at the 63th percentile and 96365 at the 68th percentile), reinforcing that the practice operates at expected volumes for chemotherapy/infusion tasks rather than as an extreme outlier. This pattern combined with the top-code concentration suggests a focused but not unusually large infusion practice footprint.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

33 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	9,800	$40	$421.4K
J0897	Injection, denosumab, 1 mg	8,880	$20	$159.8K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	670	$120	$82K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	210	$120	$24.6K
99205	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider…	60	$210	$13.7K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	130	$60	$7.6K
J1750	Injection, iron dextran, 50 mg	540	$10	$7K
80053	The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel.	630	$10	$6.3K
85025	A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a…	770	$10	$6.2K
96367	The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose…	230	$30	$6.1K

Showing 1–10 of 33

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 33 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Alaska Distribution

Lawrence Lawson — 5 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Alaska

Full comparison — all codes billed, vs. state median

33 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	10	10	13,300	$40	$609.5K
J0897	5	30	2,700	$20	$82.7K
96413	12	20	230	$110	$30.2K
99214	34	1,210	90	$100	$16.2K
99215	231	400	40	$150	$11K
99213	981	1,290	70	$70	$8.5K
99205	18	140	30	$190	$7.4K
96417	8	20	100	$60	$5.3K
J1750	1	10	390	$10	$5.2K
96365	6	30	70	$50	$4.8K

Showing 1–10 of 33

Related Providers

Other providers that share a Tax Identification Number (TIN) with Lawrence Lawson, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Colleen Kersgard	AK	Hematology & Oncology Physician	$944.9K	$0
Midnight Sun Oncology Partners, LLC	AK	Hematology & Oncology Physician	$0	$648.3K

Nearby Providers

Other providers in the same ZIP code as Lawrence Lawson, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Mat-su Valley Medical Center LLC	AK	General Acute Care Hospital	$0	$67.4M
Mat-su Emergency Medicine Physicians Corp	AK	Emergency Medicine Physician	$0	$14.3M
Co Occuring Disorders Institute	AK	Community/Behavioral Health Agency	$0	$7.3M
Division Of Alaskan Pioneer Homes	AK	Assisted Living Facility	$0	$6.1M
Matanuska-susitna Borough School District	AK	Local Education Agency (LEA)	$0	$6M
Matanuska Susitna Borough	AK	Land Ambulance	$1.2M	$4.2M
Ak Nurtured Living LLC	AK	Assisted Living Facility	$0	$5.4M
Knik Tribe	AK	Community/Behavioral Health Agency	$0	$3.8M
Daybreak Incorporated	AK	Case Management Agency	$0	$3.6M
City & Borough Of Juneau Alaska	AK	Land Ambulance	$580.5K	$2.4M

Lawrence Lawson — Billing Profile & Reimbursement Data

Sign up for Lawrence Lawson — Billing Profile & Reimbursement Data policy alerts

Lawrence Lawson — Billing Profile & Reimbursement Data

Sign up for Lawrence Lawson — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References